메뉴 건너뛰기




Volumn 30, Issue 8, 2004, Pages 817-829

Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires

Author keywords

Ageing; Carbamazepine; Formulations; Gelucires; Hydrophilic additives; Release kinetics; Semisolid matrix

Indexed keywords

ACYLGLYCEROL; AEROSIL; CARBAMAZEPINE; CROSCARMELLOSE SODIUM; DODECYL SULFATE SODIUM; EXCIPIENT; GELATIN; GELUCIRE; MACROGOL DERIVATIVE; METHYLCELLULOSE; POVIDONE;

EID: 5444230904     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-200030497     Document Type: Article
Times cited : (22)

References (32)
  • 2
    • 0024506087 scopus 로고
    • A double blind comparison of conventional and controlled release formulations of carbamazepine in healthy subjects
    • Larkin, J.G.; Mecllelan, A.; Munday, A.; Sutherland, M.; Bulter, E.; Brodie, M.J. A double blind comparison of conventional and controlled release formulations of carbamazepine in healthy subjects. Br. J. Clin. Pharm. 1989, 27, 313-322.
    • (1989) Br. J. Clin. Pharm. , vol.27 , pp. 313-322
    • Larkin, J.G.1    Mecllelan, A.2    Munday, A.3    Sutherland, M.4    Bulter, E.5    Brodie, M.J.6
  • 3
    • 0027325547 scopus 로고
    • Linear extended release of a water insoluble drug, carbamazepine, from erodible matrix
    • Giunchedi, P.; Maggi, L.; Conte, U.; La Manna, A. Linear extended release of a water insoluble drug, carbamazepine, from erodible matrix. Int. J. Pharm. 1993, 94, 15-22.
    • (1993) Int. J. Pharm. , vol.94 , pp. 15-22
    • Giunchedi, P.1    Maggi, L.2    Conte, U.3    La Manna, A.4
  • 4
    • 0031742446 scopus 로고    scopus 로고
    • Controlled multidose pharmacokinetic evaluation of two extended release carbamazepine formulations (Carbatrol and Tegretol-XR)
    • Stevens, R.E.; Limsakun, T.; Evans, G.; Mason, D.H., Jr. Controlled multidose pharmacokinetic evaluation of two extended release carbamazepine formulations (Carbatrol and Tegretol-XR). J. Pharm. Sci. 1998, 87, 1531-1534.
    • (1998) J. Pharm. Sci. , vol.87 , pp. 1531-1534
    • Stevens, R.E.1    Limsakun, T.2    Evans, G.3    Mason Jr., D.H.4
  • 5
    • 0028858553 scopus 로고
    • The Tegretol OROS Osmotic release delivery system study group, double-blind crossover comparison of Tegretol-XR and Tegretol in patients with epilepsy
    • The Tegretol OROS Osmotic release delivery system study group, double-blind crossover comparison of Tegretol-XR and Tegretol in patients with epilepsy. Neurology 1995, 45, 1703-1707.
    • (1995) Neurology , vol.45 , pp. 1703-1707
  • 6
    • 0026644232 scopus 로고
    • Formulation and physical properties of thixotropic gels for hard gelatin capsules
    • Walters, P.A.; Rowley, G.; Pearson, J.T.; Taytor, C.J. Formulation and physical properties of thixotropic gels for hard gelatin capsules. Drug Dev. Ind. Pharm. 1992, 18, 1613-1631.
    • (1992) Drug Dev. Ind. Pharm. , vol.18 , pp. 1613-1631
    • Walters, P.A.1    Rowley, G.2    Pearson, J.T.3    Taytor, C.J.4
  • 7
    • 0026531560 scopus 로고
    • The preparation of prolonged action formulations in the form of semi-solid matrix into hard gelatin capsules of oxprenolol. II Thixocap method
    • Baykara, T.; Yuksel, N. The preparation of prolonged action formulations in the form of semi-solid matrix into hard gelatin capsules of oxprenolol. II Thixocap method. Drug Dev. Ind. Pharm. 1992, 18, 233-243.
    • (1992) Drug Dev. Ind. Pharm. , vol.18 , pp. 233-243
    • Baykara, T.1    Yuksel, N.2
  • 8
    • 0032998249 scopus 로고    scopus 로고
    • Rheology of polyol behenates and drug release from matrix monolithic capsules
    • Duclos, R.; Bourret, E.; Brossard, C. Rheology of polyol behenates and drug release from matrix monolithic capsules. Int. J. Pharm. 1999, 182, 145-154.
    • (1999) Int. J. Pharm. , vol.182 , pp. 145-154
    • Duclos, R.1    Bourret, E.2    Brossard, C.3
  • 9
    • 0025279090 scopus 로고
    • Formation of sustained release wax matrices within hard gelatin capsules in fluidized bed
    • Bodmeier, R.; Paeratakul, O.; Chen, H.; Zhang, W. Formation of sustained release wax matrices within hard gelatin capsules in fluidized bed. Drug Dev. Ind. Pharm. 1990, 16, 1505-1519.
    • (1990) Drug Dev. Ind. Pharm. , vol.16 , pp. 1505-1519
    • Bodmeier, R.1    Paeratakul, O.2    Chen, H.3    Zhang, W.4
  • 10
    • 0029553277 scopus 로고
    • In vivo evaluation of an indomethacin monolithic, extended zero-order release hard gelatin capsule formulation based on saturated polyglycolyzed glycerides
    • Vial-Bernasconi, A.C.; Buri, P.; Doelker, E.; Beyssac, E.; Duchaix, G.; Aiache, J.M. In vivo evaluation of an indomethacin monolithic, extended zero-order release hard gelatin capsule formulation based on saturated polyglycolyzed glycerides. Pharm. Acta Helv. 1995, 70, 307-313.
    • (1995) Pharm. Acta Helv. , vol.70 , pp. 307-313
    • Vial-Bernasconi, A.C.1    Buri, P.2    Doelker, E.3    Beyssac, E.4    Duchaix, G.5    Aiache, J.M.6
  • 11
    • 0025856627 scopus 로고
    • Modelling of theophylline compound release from hard gelatin capsules containing Gelucire matrix granules
    • Brossard, C.; Ratsimbazafy, V.; Lefort des Ylouses, D. Modelling of theophylline compound release from hard gelatin capsules containing Gelucire matrix granules. Drug Dev. Ind. Pharm. 1991, 17, 1262-1277.
    • (1991) Drug Dev. Ind. Pharm. , vol.17 , pp. 1262-1277
    • Brossard, C.1    Ratsimbazafy, V.2    Lefort Des Ylouses, D.3
  • 12
    • 0032711894 scopus 로고    scopus 로고
    • Rheological behavior of drug suspensions in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsules
    • Ratsimbazafy, V.; Bourret, E.; Duclos, R.; Brossard, C. Rheological behavior of drug suspensions in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsules. Eur. J. Pharm. Biopharm. 1999, 48, 247-252.
    • (1999) Eur. J. Pharm. Biopharm. , vol.48 , pp. 247-252
    • Ratsimbazafy, V.1    Bourret, E.2    Duclos, R.3    Brossard, C.4
  • 13
    • 2242485534 scopus 로고
    • Modulation de la cinetique et de la vitesse de liberation par un choix adequat de l'excipient: Exemple des Gelucires
    • Buri, P.; Vial-Bernasconi, A.C.; Doelker, E. Modulation de la cinetique et de la vitesse de liberation par un choix adequat de l'excipient: exemple des Gelucires. Bull. Tech. Gattefosse 1985, 78, 67-73.
    • (1985) Bull. Tech. Gattefosse , vol.78 , pp. 67-73
    • Buri, P.1    Vial-Bernasconi, A.C.2    Doelker, E.3
  • 14
    • 0026588498 scopus 로고
    • Accelerated stability study of sustained-release nifedipine tablets prepared with Gelucire
    • Remunan, C.; Bretal, M.J.; Nunez, A.; Jato, J.L.V. Accelerated stability study of sustained-release nifedipine tablets prepared with Gelucire. Int. J. Pharm. 1992, 80, 151-159.
    • (1992) Int. J. Pharm. , vol.80 , pp. 151-159
    • Remunan, C.1    Bretal, M.J.2    Nunez, A.3    Jato, J.L.V.4
  • 15
    • 0037026276 scopus 로고    scopus 로고
    • Physical stability of solid dispersions of the antiviral agent UC-781 with PEG6000, Gelucire 44/14 and PVP K30
    • Damian, F.; Blaton, N.; Kinget, R.; Van-den-Mooter, G. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG6000, Gelucire 44/14 and PVP K30. Int. J. Pharm. 2002, 244, 87-98.
    • (2002) Int. J. Pharm. , vol.244 , pp. 87-98
    • Damian, F.1    Blaton, N.2    Kinget, R.3    Van-den-Mooter, G.4
  • 16
    • 0034605706 scopus 로고    scopus 로고
    • Effect of aging on the release of salbutamol sulfate from lipid matrices
    • San-Vicente, A.; Hernandez, R.M.; Gascon, M.B.; Pedraz, J.L. Effect of aging on the release of salbutamol sulfate from lipid matrices. Int. J. Pharm. 2000, 205, 13-21.
    • (2000) Int. J. Pharm. , vol.205 , pp. 13-21
    • San-Vicente, A.1    Hernandez, R.M.2    Gascon, M.B.3    Pedraz, J.L.4
  • 17
    • 0029009997 scopus 로고
    • Investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases
    • Sutananta, W.; Craig, D.Q.M.; Newton, J.M. Investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases. J. Pharm. Phamacol. 1995, 47, 355-359.
    • (1995) J. Pharm. Phamacol. , vol.47 , pp. 355-359
    • Sutananta, W.1    Craig, D.Q.M.2    Newton, J.M.3
  • 18
    • 0023934714 scopus 로고
    • On the structural behaviour of triglycerides with time
    • Laine, E.; Auramo, P.; Kahela, P. On the structural behaviour of triglycerides with time. Int. J. Pharm. 1988, 43, 241-247.
    • (1988) Int. J. Pharm. , vol.43 , pp. 241-247
    • Laine, E.1    Auramo, P.2    Kahela, P.3
  • 20
    • 0021904208 scopus 로고
    • Analysis of fickian and non fickian drug release from polymers
    • Peppas, N.A. Analysis of fickian and non fickian drug release from polymers. Pharm. Acta Helv. 1985, 60, 110-111.
    • (1985) Pharm. Acta Helv. , vol.60 , pp. 110-111
    • Peppas, N.A.1
  • 21
    • 0024820780 scopus 로고
    • A simple equation for the description of solute release III. Coupling of diffusion and relaxation
    • Peppas, N.A.; Sahlin, J.J. A simple equation for the description of solute release III. Coupling of diffusion and relaxation. Int. J. Pharm. 1989, 57, 169-172.
    • (1989) Int. J. Pharm. , vol.57 , pp. 169-172
    • Peppas, N.A.1    Sahlin, J.J.2
  • 22
    • 0018353022 scopus 로고
    • Release mechanisms in gel forming sustained release preparations
    • Bamba, M.; Puisieux, F.; Marty, J.P.; Carstensen, J.T. Release mechanisms in gel forming sustained release preparations. Int. J. Pharm. 1979, 2, 307-315.
    • (1979) Int. J. Pharm. , vol.2 , pp. 307-315
    • Bamba, M.1    Puisieux, F.2    Marty, J.P.3    Carstensen, J.T.4
  • 23
    • 0025884646 scopus 로고
    • Release of chlorpheniramine maleate from fatty acid ester matrix disks prepared by melt-extrusion
    • Prapaitrakul, W.; Sprockel, O.L. Shivanand. Release of chlorpheniramine maleate from fatty acid ester matrix disks prepared by melt-extrusion. J. Pharm. Pharmacol. 1991, 43, 337-381.
    • (1991) J. Pharm. Pharmacol. , vol.43 , pp. 337-381
    • Prapaitrakul, W.1    Sprockel2    Shivanand, O.L.3
  • 24
    • 0022449582 scopus 로고
    • The incorporation and in-vitro release profiles of liquid, deliquescent or unstable drugs with fusible excipients in hard gelatin capsules
    • Doelker, C.; Doelker, E.; Buri, P.; Waginaire, L. The incorporation and in-vitro release profiles of liquid, deliquescent or unstable drugs with fusible excipients in hard gelatin capsules. Drug Dev. Ind. Pharm. 1986, 12, 1553-1565.
    • (1986) Drug Dev. Ind. Pharm. , vol.12 , pp. 1553-1565
    • Doelker, C.1    Doelker, E.2    Buri, P.3    Waginaire, L.4
  • 25
    • 0028948829 scopus 로고
    • Evaluation of the mechanism of drug release from glyceride bases
    • Sutananta, W.; Craig, D.Q.M.; Newton, J.M. Evaluation of the mechanism of drug release from glyceride bases. J. Pharm. Pharmacol. 1995, 47, 182-187.
    • (1995) J. Pharm. Pharmacol. , vol.47 , pp. 182-187
    • Sutananta, W.1    Craig, D.Q.M.2    Newton, J.M.3
  • 26
    • 0011367739 scopus 로고
    • In vitro evaluation of a mixed polymeric sustained-release matrix using response surface methodology
    • Franz, R.M.; Sytsma, J.A.; Smith, B.P.; Lucisano, LJ. In vitro evaluation of a mixed polymeric sustained-release matrix using response surface methodology. J. Control. Release 1987, 5, 159-172.
    • (1987) J. Control. Release , vol.5 , pp. 159-172
    • Franz, R.M.1    Sytsma, J.A.2    Smith, B.P.3    Lucisano, L.J.4
  • 27
    • 0025730397 scopus 로고
    • The preparation of prolonged action formulations in the form of semi-solid matrix into hard gelatin capsules of oxprenolol. I Thermocap method
    • Baykara, T.; Yuksel, N. The preparation of prolonged action formulations in the form of semi-solid matrix into hard gelatin capsules of oxprenolol. I Thermocap method. Drug Dev. Ind. Pharm. 1991, 17, 1215-1227.
    • (1991) Drug Dev. Ind. Pharm. , vol.17 , pp. 1215-1227
    • Baykara, T.1    Yuksel, N.2
  • 28
    • 0024443603 scopus 로고
    • Encapsulation and in vitro release of indomethacin from semi-solid matrix capsules
    • Naidoo, N.T. Encapsulation and in vitro release of indomethacin from semi-solid matrix capsules. Int. J. Pharm. 1989, 55, 53-57.
    • (1989) Int. J. Pharm. , vol.55 , pp. 53-57
    • Naidoo, N.T.1
  • 29
    • 0025915666 scopus 로고
    • Effects of two different kinds of silicon dioxide on release of drugs from suppositories: Benzydamine hydrochloride
    • Dah, Z.U.; Realdon, N.; Ragazzi, E.; Dalla, F.G. Effects of two different kinds of silicon dioxide on release of drugs from suppositories: benzydamine hydrochloride. Farmaco 1991, 46, 699-711.
    • (1991) Farmaco , vol.46 , pp. 699-711
    • Dah, Z.U.1    Realdon, N.2    Ragazzi, E.3    Dalla, F.G.4
  • 30
    • 0027990993 scopus 로고
    • The effects of ageing on the thermal behaviour and mechanical properties of pharmaceutical glycerides
    • Sutananta, W.; Craig, D.Q.M.; Newton, J.M. The effects of ageing on the thermal behaviour and mechanical properties of pharmaceutical glycerides. Int. J. Pharm. 1994, 111, 51-62.
    • (1994) Int. J. Pharm. , vol.111 , pp. 51-62
    • Sutananta, W.1    Craig, D.Q.M.2    Newton, J.M.3
  • 31
    • 5444229074 scopus 로고    scopus 로고
    • Effect of physical structure of Gelucire 50/13 on the release of theophylline from a Gelucire 50/ 13-theophylline formulation
    • Duddu, S.P.; Roussin, P.; Laforet, J.P.; Palepu, N.R. Effect of physical structure of Gelucire 50/13 on the release of theophylline from a Gelucire 50/ 13-theophylline formulation. Bull Tech. Gattefosse 1996, No 89, 53-59.
    • (1996) Bull Tech. Gattefosse , vol.89 , pp. 53-59
    • Duddu, S.P.1    Roussin, P.2    Laforet, J.P.3    Palepu, N.R.4
  • 32
    • 0038246450 scopus 로고    scopus 로고
    • Semisolid matrix filled capsules: An approach to improve dissolution stability of phenytoin sodium formulation
    • El Massik, M.A.; Abdallah, O.Y.; Galal, S.; Daabis, N.A. Semisolid matrix filled capsules: An approach to improve dissolution stability of phenytoin sodium formulation. Drug Dev. Ind. Pharm. 2003, 29, 531-543.
    • (2003) Drug Dev. Ind. Pharm. , vol.29 , pp. 531-543
    • El Massik, M.A.1    Abdallah, O.Y.2    Galal, S.3    Daabis, N.A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.